<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28225968</article-id>
      <article-id pub-id-type="pmc">5312190</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20174502</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Atypical cellular blue nevus or malignant blue nevus?<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Daltro</surname>
            <given-names>Luise Ribeiro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yaegashi</surname>
            <given-names>Lygia Bertalha</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freitas</surname>
            <given-names>Rodrigo Abdalah</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fantini</surname>
            <given-names>Bruno de Carvalho</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Souza</surname>
            <given-names>Cacilda da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Division of Dermatology, Internal Medicine Department -
Medical School of Ribeir&#xE3;o Preto - Universidade de S&#xE3;o Paulo-
Ribeir&#xE3;o Preto (SP) -Brazil.</aff>
      <aff id="aff2"><label>2</label>Department of Pathology - Medical School of
Ribeir&#xE3;o Preto - Universidade de S&#xE3;o Paulo- Ribeir&#xE3;o Preto (SP)
-Brazil.</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Cacilda da Silva Souza, Hospital das
Cl&#xED;nicas, Divis&#xE3;o de Dermatologia, Campus Universit&#xE1;rio,
s/n, Monte Alegre, 14048-900 - Ribeir&#xE3;o Preto - SP, Brazil. E-mail:
<email>cssouza@fmrp.usp.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2017</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2017</year>
      </pub-date>
      <volume>92</volume>
      <issue>1</issue>
      <fpage>110</fpage>
      <lpage>112</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2017 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Blue nevus is a benign melanocytic lesion whose most frequent variants are
dendritic (common) blue nevus and cellular blue nevus. Atypical cellular blue
nevus presents an intermediate histopathology between the typical and a rare
variant of malignant blue nevus/melanoma arising in a cellular blue nevus. An
8-year-old child presented a pigmented lesion in the buttock since birth, but
with progressive growth in the last two years. After surgical excision,
histopathological examination revealed atypical cellular blue nevus. Presence of
mitoses, ulceration, infiltration, cytological atypia or necrosis may occur in
atypical cellular blue nevus, making it difficult to differentiate it from
melanoma. The growth of blue nevus is unusual and considered of high-risk for
malignancy, being an indicator for complete resection and periodic follow-up of
these patients.</p>
      </abstract>
      <kwd-group>
        <kwd>Melanoma</kwd>
        <kwd>Nevus, blue</kwd>
        <kwd>Nevus, pigmented</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Blue nevus (BN) and related entities are a heterogeneous group of congenital and
acquired melanocytic tumors that includes dendritic ("common") blue nevus (DBN),
cellular blue nevus (CBN), and variants, as atypical cellular blue nevus (ACBN) and
malignant BN/melanoma.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> They share several clinical and
morphologic features including their blue tinctorial properties; dermal
proliferation of spindle, fusiform or ovoid cells; melanin pigment inside both the
melanocytic tumor cells and macrophages; and variably stromal fibrosis and collagen
amounts. Immunophenotypically, the tumors have positivity for HMB-45 (Gp100), S-100
and Melan-A/Mart-1 expression. <sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>CBN differs from the classic DBN by its large size, cellularity, intense
pigmentation, and growing pattern with subcutaneous infiltration, but with variable
overlapping. Additional atypical features associated with variety of CBN
histological patterns, but without clear-cut evidence of malignancy, has been
referred to as ACBN, and it can be difficult to it distinguish from
melanoma.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Malignant BN is a very rare form of
melanoma, arising in association with or exhibiting some morphologic similarities to
BN.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> In view of
its rarity, the relevance and the challenge of differentiating it from its malignant
variant, we report a case of congenital BN with progressive growth, histologically
consistent with an atypical CBN.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>An 8-year-old boy was presented with a dark lesion on buttock, since birth, but with
a progressive growth in two years. Physical examination revealed a dark blue nodule
with homogeneous pigmentation, symmetrical and regular borders, with 2.5 cm in
diameter on the left gluteus, with no palpable lymph nodes (<xref ref-type="fig" rid="f1">Figure 1A</xref>). Dermoscopy revealed a homogeneous and structureless
pigment pattern of grayish-brown color, and a slightly irregular surface (<xref ref-type="fig" rid="f1">Figure 1B</xref>). Surgical excision was performed with
5mm margin due to the difficulty in delimiting the lesion. Histological examination
revealed a solid melanocytic lesion, composed by hypercellular nests affecting the
entire dermis and part of subcutaneous tissue (<xref ref-type="fig" rid="f2">Figure
2</xref>). In the nest extremity, there were dendritic pigmented cells; in the
center, ovoid and pale cells, with intermediate size; and focally, pleomorphic and
vesicular nuclei, evident nucleoli, and occasional mitosis &lt;2/mm<sup>2</sup>,
which was compatible with ACBN (<xref ref-type="fig" rid="f3">Figures 3</xref> and
<xref ref-type="fig" rid="f4">4</xref>).</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>A)</bold> Nodule with dark blue homogeneous pigmentation,
symmetrical and regular borders, measuring 2.5 cm in diameter on
gluteus; <bold>B)</bold> Dermoscopy exhibited a homogeneous and
structureless pigment pattern of grayish-brown color, more evident in
the follicular ostia</p>
          </caption>
          <graphic xlink:href="abd-92-01-0110-gf01"/>
        </fig>
      </p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Melanocyte proliferation occupying papillar and reticular dermis, and
forming nests; no alteration in the epidermis was observed (Hematoxylin
&amp; eosin x40)</p>
          </caption>
          <graphic xlink:href="abd-92-01-0110-gf02"/>
        </fig>
      </p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Nests compose of heavily pigmented and dendritic melanocytes in the
periphery; pale and ovoid melanocytes of intermediate size in the center
were consistent with cellular blue nevus (Hematoxylin &amp; eosin
x100)</p>
          </caption>
          <graphic xlink:href="abd-92-01-0110-gf03"/>
        </fig>
      </p>
      <p>
        <fig id="f4" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Pleomorphic and vesicular nuclei, evident nucleoli, and occasional
mitosis (&lt;2/mm<sup>2</sup>) were compatible with atypical cellular
blue nevus (Hematoxylin &amp; eosin x400)</p>
          </caption>
          <graphic xlink:href="abd-92-01-0110-gf04"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>BN usually appears in childhood or adolescence and is rarely congenital.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> The most common form, DBN, is presented as a solitary,
symmetrical and intensely pigmented papule or nodule measuring less than 1cm and
occurs mainly on the back of the hands or feet; or locations as face and
scalp.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> It can affect mucous membranes and extracutaneous
sites. CBN variant is a nodule or plaque, usually 1 to 3 cm in diameter, with smooth
or irregular surface, most commonly found in the glutei, sacrococcygeal area or
scalp.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> Growth is unusual and should raise suspicion of
malignant degeneration.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>Malignant BN has usually a multinodular appearance, with progressive growth and, in
general, more than 3 cm in diameter, and located on the scalp.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> It can arise from a BN, nevus of Ota
or Ito or <italic>de novo,</italic> and its biological behavior is
uncertain.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> Malignant degeneration has unknown
incidence and prognosis, with a high rate of recurrence and metastasis, especially
to lymph nodes.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup> High risk characteristics for
malignancy in a BN are: size &gt;2 cm, multinodular surface, location in scalp and
growth.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> It is believed that BN derives from an incomplete migration of
melanocytes precursor cells, coming from the neural crest, on its way to the
epidermis. Histologically, there are dendritic melanocytes, grouped in the upper and
middle dermis, with active melanin production, whereas in compound and intradermal
nevi, dermal melanocytes do not produce, or produce little, melanin.<sup><xref rid="r1" ref-type="bibr">1</xref></sup></p>
      <p>CBN differentiates from DBN by pigmented melanocytes in the dermis, grouped spindle
cells containing little or none melanin, that frequently penetrate the subcutaneous
layer as well-defined islands.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> Although,
there is no uniform criteria for the distinction, high mitotic activity (&gt;2/mm2),
marked cytological atypia, necrosis, deep infiltration and atypical mitotic figures
favor melanoma.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup> At least one of the
following findings characterizes CBN as atypical: asymmetry, focal infiltration or
hypercellularity, pleomorphism with hyperchromasia, proeminent nucleoli, and
occasional mitoses (&lt; 2/mm<sup>2</sup>) . <sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r6" ref-type="bibr">6</xref></sup></p>
      <p>Because of the overlapping intermediate features between atypical CBN and malignant
BN/melanoma, its distinction remains a challenge.<sup><xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup> ACBNs tend to show a
higher proliferative index by proliferating cell nuclear antigen (PCNA) and Mib-1 as
well as a significantly higher mitotic rate compared with typical CBN.</p>
      <p>Argyrophilic nucleolar organizer regions (AgNORs) expression has been considered in
skin melanocytic lesion prognosis. AgNOR mean number per nucleus (AgNOR count),
their distribution (configuration) and the ratio AgNOR area/nuclear area can be
useful to discriminate benign from malignant melanocytic lesions, although with
considerable overlap. Usually, there is a linear relation between AgNOR counts and
PCNA immunostaining scores, which can be additional parameters for the diagnosis of
malignant CBN.<sup><xref rid="r7" ref-type="bibr">7</xref></sup></p>
      <p>Molecular techniques of the primary tumor such as comparative genomic hybridization
(CGH) or fluorescence in situ hybridization may assist in establishing a melanoma
diagnosis. However, these tests require further independent validation and are not
widely available at present.<sup><xref rid="r8" ref-type="bibr">8</xref></sup></p>
      <p>CGH of some cases of large plaque-type BN with subcutaneous cellular nodules have
showed chromosomal aberrations typical of melanoma. Nodules showed gains involving
chromosome 6p and losses involving chromosome 6q, which are among the most commonly
found aberrations in melanoma. In the less cellular surrounding areas that appeared
BN representative, these copy number aberrations were not present.<sup><xref rid="r9" ref-type="bibr">9</xref></sup></p>
      <p>Large BN with a deep, multi-nodular configuration should be interpreted with caution,
and superficial biopsy can be misleading. Patients with histologically ambiguous
dermal melanocytic proliferations that exhibit copy number aberrations should
undergo careful clinical follow-up.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>Somatic mutations in codon 209 of GNAQ, a gene encoding the signaling protein
G-protein &#x3B1; subunit q, may be present in up to 80% of BN.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The difficult distinction of ACBN from melanoma associated with growth, a high-risk
malignancy characteristic, but unusual in CBN, justify its complete resection and
long-term follow-up of these patients. Further studies including molecular and
genetic analysis will provide valuable insights and may be useful in differentiating
atypical CBN from malignant BN, but the accurate history and physical examination,
with attention to the lesion growth, remain fundamental for early intervention.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Study conducted at Hospital das Cl&#xED;nicas da Faculdade de Medicina de
Ribeir&#xE3;o Preto- Universidade de S&#xE3;o Paulo (FMRP-USP) -
Ribeir&#xE3;o Preto</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murali</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Scolyer</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Blue nevi and related lesions: a review highlighting atypical and
newly described variants, distinguishing features and diagnostic
pitfalls</article-title>
          <source>Adv Anat Pathol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>365</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">19851128</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Barnhill</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Rabinovitz</surname>
              <given-names>Harold</given-names>
            </name>
          </person-group>
          <person-group person-group-type="author">
            <name>
              <surname>Bolognia</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jorizzo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rapini</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <source>Dermatologia</source>
          <chapter-title>Neoplasias melanoc&#xED;ticas benignas</chapter-title>
          <year>2011</year>
          <edition>2</edition>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>Elsevier</publisher-name>
          <fpage>1722</fpage>
          <lpage>1723</lpage>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zembowicz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mihm</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Dermal dendritic melanocytic proliferations: an
update</article-title>
          <source>Histopathology</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>433</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">15500647</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnhill</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Argenyi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Berwick</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Duray</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Erickson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Guitart</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atypical cellular blue nevi (cellular blue nevi with atypical
features): lack of consensus for diagnosis and distinction from cellular
blue nevi and malignant melanoma ("malignant blue nevus")</article-title>
          <source>Am J Surg Pathol</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>36</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="pmid">18162768</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Carlson</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Basaca</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Mihm</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Cellular blue nevus with atypia (atypical cellular blue nevus): a
clinicopathologic study of nine cases</article-title>
          <source>J Cutan Pathol</source>
          <year>1998</year>
          <volume>25</volume>
          <fpage>252</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="pmid">9696290</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnhill</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cook</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Elder</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Kerl</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>LeBoit</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>State of the art, nomenclature, and points of consensus and
controversy concerning benign melanocytic lesions outcome of an
international workshop</article-title>
          <source>Adv Anat Pathol</source>
          <year>2010</year>
          <volume>17</volume>
          <fpage>73</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">20179431</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pich</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chiusa</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Margaria</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Role of the argyrophilic nucleolar organizer regions in tumor
detection and prognosis</article-title>
          <source>Cancer Detect Prev</source>
          <year>1995</year>
          <volume>19</volume>
          <fpage>282</fpage>
          <lpage>291</lpage>
          <pub-id pub-id-type="pmid">7750118</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scolyer</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Murali</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Histologically ambiguous ("borderline") primary cutaneous
melanocytic tumors: approaches to patient management including the roles of
molecular testing and sentinel lymph node biopsy</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>2010</year>
          <volume>134</volume>
          <fpage>1770</fpage>
          <lpage>1777</lpage>
          <pub-id pub-id-type="pmid">21128774</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Yeh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>McCalmont</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>LeBoit</surname>
              <given-names>PE</given-names>
            </name>
          </person-group>
          <article-title>Melanoma ex blue nevus: two cases resembling large plaque-type
blue nevus with subcutaneous cellular nodules</article-title>
          <source>J Cutan Pathol</source>
          <year>2012</year>
          <volume>39</volume>
          <fpage>1094</fpage>
          <lpage>1099</lpage>
          <pub-id pub-id-type="pmid">23145498</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Held</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Eigentler</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Metzler</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Leiter</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Messina</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Glass</surname>
              <given-names>LF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proliferative activity, chromosomal aberrations, and
tumor-specific mutations in the differential diagnosis between blue nevi and
melanoma</article-title>
          <source>Am J Pathol</source>
          <year>2013</year>
          <volume>182</volume>
          <fpage>640</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">23261261</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
